Trial Profile
A multi-centric Phase II study of intraperitoneal docetaxel combined with S-1 for patients with peritoneal dissemination of gastric cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Nov 2011
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Adverse reactions
- 11 Nov 2011 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 11 May 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 17 Nov 2009 New trial record